Endothelial Cell Behavior and Nitric Oxide Production on a-C:H:SiO_x-Coated Ti-6Al-4V Substrate

Area of Science:

• Biomaterials Science
• Surface Engineering
• Materials Science

Background:

• Ti-6Al-4V alloy is widely used in medical implants.
• Surface modification is crucial for improving biocompatibility and device performance.
• Controlling endothelial cell response is vital for implant success.

Purpose of the Study:

• To investigate the surface modification of Ti-6Al-4V alloy using amorphous hydrogenated silicon oxycarbide (a-C:H:SiO_x) coatings.
• To characterize the structure and chemical bonding of the a-C:H:SiO_x coating.
• To evaluate the in vitro biological response of endothelial cells to the coated surface.

Main Methods:

• Deposition of a-C:H:SiO_x coatings on Ti-6Al-4V substrates.
• Transmission electron microscopy (TEM) for structural analysis.
• Analysis of atomic radial distribution function (RDF) to model short-range order.
• Identification of chemical bonds (C-O, C-C, Si-C, Si-O, Si-Si).
• In vitro endothelization assays with EA.hy926 endothelial cells.
• Cytotoxicity testing and assessment of cell adhesion, number, and nitric oxide production.

Main Results:

• A model for the atomic short-range order structure of the a-C:H:SiO_x coating was proposed.
• Key chemical bonds within the coating were identified.
• The a-C:H:SiO_x coating exhibited no prolonged cytotoxicity towards EA.hy926 cells.
• Significantly lower adhesion, cell number, and nitric oxide production by endothelial cells were observed on the coated surface compared to the uncoated Ti-6Al-4V.

Conclusions:

• The a-C:H:SiO_x coating effectively modifies the Ti-6Al-4V surface.
• The coating demonstrates good biocompatibility with endothelial cells.
• Reduced endothelial cell activity suggests a potential to mitigate hyperproliferation on medical implants.
• The findings support the use of a-C:H:SiO_x coatings for devices like heart valves, stents, and circulatory support systems.